Empyrean Capital Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-228,000
Closed -$30.1M 86
2025
Q1
$30.1M Buy
+228,000
New +$30.1M 1.07% 21